#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17482	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2127	816.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1426	1426	C	1043	C,A	955,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32134	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	913.0	0	.	n	.	0	T695C	SNP	695	695	T	976	976	C	968	C,A	892,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32134	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	913.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1618	1618	A	1052	A	969	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32134	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	913.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2252	2252	C	1071	C	970	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32134	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	913.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2326	2326	A	1066	A	987	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32134	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3507	913.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2878	2878	C	951	C,T,A	428,454,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2258	folP	852	852	100.0	folP.l15.c30.ctg.1	1557	144.6	1	SNP	p	R228S	1	.	.	682	684	AGC	971	973	AGC	266;264;266	A;G;C	252;250;248	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5512	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3310	166.0	1	SNP	p	S91F	0	.	.	271	273	TCC	574	576	TCC	230;233;237	T;C,T;C	213;215,1;218	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5512	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3310	166.0	1	SNP	p	D95G	0	.	.	283	285	GAC	586	588	GAC	225;224;225	G;A,G;C	203;203,1;205	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5512	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3310	166.0	1	SNP	p	D95N	0	.	.	283	285	GAC	586	588	GAC	225;224;225	G;A,G;C	203;203,1;205	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1780	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1425	124.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	524	526	ACC	202;204;202	A;C;C	184;190;187	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1780	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1425	124.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	539	541	CAC	216;216;217	C;A;C	198;196;200	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1780	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1425	124.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	722	724	CAC	221;221;220	C;A;C	200;197;199	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1780	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1425	124.6	1	SNP	p	G45D	0	.	.	133	135	GGC	542	544	GGC	215;217;218	G;G;C	198;197;199	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	974	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	899	106.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6090	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2904	208.9	1	SNP	p	D86N	0	.	.	256	258	GAC	557	559	GAC	239;238;241	G;A;C	223;222;227	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6090	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2904	208.9	1	SNP	p	S87R	0	.	.	259	261	AGT	560	562	AGT	248;246;247	A;G;T	232;229;228	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6090	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2904	208.9	1	SNP	p	S87W	0	.	.	259	261	AGT	560	562	AGT	248;246;247	A;G;T	232;229;228	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6090	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2904	208.9	1	SNP	p	S87I	0	.	.	259	261	AGT	560	562	AGT	248;246;247	A;G;T	232;229;228	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6090	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2904	208.9	1	SNP	p	S88P	0	.	.	262	264	TCC	563	565	TCC	244;246;246	T;C;C	227;227;225	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4856	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2524	191.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1471	1473	GGC	232;228;229	G;G;C	217;213;211	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1213	1215	GCA	243;240;240	G;C;A	213;209;214	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1216	1218	ATC	238;238;238	A;T;C	210;213;213	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1228	1230	GTG	235;230;229	G;T;G	210;207;207	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1228	1230	GTG	235;230;229	G;T;G	210;207;207	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1732	1734	ACC	243;242;241	A;C;C,A	219;220;219,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1786	1788	GCG	225;222;221	G;C;G	193;171;184	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1786	1788	GCG	225;222;221	G;C;G	193;171;184	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1909	1911	GGC	196;198;199	G;G;C	181;182;180	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1918	1920	GGC	195;193;190	G;G;C	171;170;171	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4506	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2269	197.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1936	1938	CCG	151;151;153	C,G;C,G;G	110,6;117,1;115	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6786	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	2973	227.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1555	1557	CTG	257;254;257	C;T;G	229;228;231	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2484	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1832	134.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	507	507	C	189	C	173	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	443	445	GGA	311;311;312	G;G;A	283;287;286	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	560	562	GCT	236;237;240	G;C;T	215;217;214	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	704	706	CTT	246;248;252	C;T,C;T	221;219,1;223	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	728	730	GGA	247;248;248	G;G;A	221;219;218	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	D171G	NONSYN	511	513	GAT	812	814	GGT	256;258;262	G;G;T	237;240;239	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	G189S	NONSYN	565	567	GGC	866	868	AGC	258;255;258	A;G;C	234;233;236	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	932	932	T	216	T	208	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	1	SNP	p	G120K	0	.	.	358	360	GGT	659	661	GGT	257;256;256	G;G;T	236;238;231	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	1	SNP	p	A121N	0	.	.	361	363	GCC	662	664	GCC	255;255;256	G;C,A;C,A	232;235,1;233,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3240	porB1b	1035	1035	95.73	porB1b.l15.c17.ctg.1	1482	216.5	1	SNP	p	A121D	0	.	.	361	363	GCC	662	664	GCC	255;255;256	G;C,A;C,A	232;235,1;233,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12990	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5054	256.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2085	2087	AAT	285;283;282	A,C;A;T	263,1;260;259	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1298	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1048	122.9	1	SNP	p	V57M	1	.	.	169	171	ATG	542	544	ATG	255;257;256	A;T;G	245;245;245	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
